Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade

BACKGROUND: Assessment of therapeutic activity of drugs blocking immune checkpoints such as CTLA-4 and PD-1/PD-L1 can be challenging, as tumors may seem to enlarge or appear anew before regressing, due to intratumoral inflammation. We assessed whether circulating tumor DNA (ctDNA) levels could serve...

Descripción completa

Detalles Bibliográficos
Autores principales: Lipson, Evan J, Velculescu, Victor E, Pritchard, Theresa S, Sausen, Mark, Pardoll, Drew M, Topalian, Suzanne L, Diaz, Luis A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4267741/
https://www.ncbi.nlm.nih.gov/pubmed/25516806
http://dx.doi.org/10.1186/s40425-014-0042-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4267741/
https://www.ncbi.nlm.nih.gov/pubmed/25516806
http://dx.doi.org/10.1186/s40425-014-0042-0

Ejemplares similares